| 1 |
Sriamornsak P, Dass CR. Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing. Pharmaceutics 2022;14:935. [DOI: 10.3390/pharmaceutics14050935] [Reference Citation Analysis]
|
| 2 |
Wong CY, Ong HX, Traini D. The application of in vitro cellular assays for analysis of electronic cigarettes impact on the airway. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120487] [Reference Citation Analysis]
|
| 3 |
Wong CYJ, Al-Salami H, Dass CR. β-Cyclodextrin-containing chitosan-oligonucleotide nanoparticles improve insulin bioactivity, gut cellular permeation and glucose consumption. J Pharm Pharmacol 2021;73:726-39. [PMID: 33769519 DOI: 10.1093/jpp/rgaa052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Wong CY, Al-Salami H, Dass CR. Fabrication techniques for the preparation of orally administered insulin nanoparticles. J Drug Target 2021;29:365-86. [PMID: 32876505 DOI: 10.1080/1061186X.2020.1817042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Wong CY, Al-Salami H, Dass CR. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol 2020;72:1667-93. [PMID: 32812252 DOI: 10.1111/jphp.13359] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 6 |
Wong CY, Martinez J, Zhao J, Al-Salami H, Dass CR. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: statistical optimization and physicochemical characterization. Drug Dev Ind Pharm 2020;46:1238-52. [PMID: 32597264 DOI: 10.1080/03639045.2020.1788061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 7 |
Wong CY, Al-salami H, Dass CR. Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles. Journal of Drug Targeting 2020;28:882-903. [DOI: 10.1080/1061186x.2020.1759078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 8 |
Wong CY, Al-Salami H, Dass CR. Lyophilisation Improves Bioactivity and Stability of Insulin-Loaded Polymeric-Oligonucleotide Nanoparticles for Diabetes Treatment. AAPS PharmSciTech 2020;21:108. [PMID: 32215761 DOI: 10.1208/s12249-020-01648-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Wong CY, Al-salami H, Dass CR. Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review. Journal of Drug Targeting 2020;28:585-99. [DOI: 10.1080/1061186x.2020.1726356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 10 |
Wang Z, Zhi K, Ding Z, Sun Y, Li S, Li M, Pu K, Zou J. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force. Semin Cancer Biol 2021;69:77-90. [PMID: 31962173 DOI: 10.1016/j.semcancer.2019.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Wong CY, Luna G, Martinez J, Al-Salami H, Dass CR. Bio-nanotechnological advancement of orally administered insulin nanoparticles: Comprehensive review of experimental design for physicochemical characterization. Int J Pharm 2019;572:118720. [PMID: 31715357 DOI: 10.1016/j.ijpharm.2019.118720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
